GI Research Club - ASIDE

🚀 Get your paper published (with DOI) in <1 month! @GiResearchClub 📢 ASIDE Gastroenterology — led by Editor-in-Chief Dr. Hazem Abosheaishaa — is now accepting submissions across all areas of GI & Hepatology. ✅ Peer-reviewed & open access ✅ No submission or publication fees ✅ Fast-track review (~3–4 weeks) ✅ Immediate DOI assignment upon acceptance ✅ Covers the full spectrum of digestive health — • Inflammatory Bowel Disease (IBD) • GI Motility & Functional Disorders • Liver & Biliary Disease • Diagnostic & Therapeutic Endoscopy • Advanced Endoscopy (EUS, ERCP, ESD, POEM, Endo-bariatrics) Be part of a growing international platform shaping the future of digestive health research. 🔗 Submit now: asidejournals.com/index.php/Gast… @AmCollegeGastro @AASLDtweets #ACG2025 #DDW2026 #AASLD #Gastroenterology #Hepatology #OpenAccess #MedTwitter #GITwitter #LiverTwitter #Endoscopy #GIResearch #AcademicMedicine #MedEd #GIComm

A new study by Abdallfatah et al. published in the Scandinavian Journal of Gastroenterology (Q2, IF 2) Congratulations to the team @HazemAbosheaish @DoniaHamed05

🔍 EFTR vs. STER for upper GI lesions: New meta-analysis in JCG (n=725) shows EFTR yields higher en bloc & complete resection rates with lower recurrence, but both are comparable in safety. journals.lww.com/jcge/abstract/…

🚨 New Publication Alert! Excited to share our latest critical review at ASIDE Internal Medicine: @GiResearchClub “TriNetX and Real-World Evidence: A Critical Review of Its Strengths, Limitations, and Bias Considerations in Clinical Research” 📌 PubMed: pubmed.ncbi.nlm.nih.gov/40697879/ In this paper, we critically evaluate TriNetX, a leading real-world data platform, focusing on: ✅ Strengths in large-scale clinical research ⚠️ Limitations related to retrospective data, selection bias, and EHR coding accuracy 📊 Generalizability challenges due to limited demographic diversity 🔍 The importance of data validation and standardization in real-world studies As the use of real-world data continues to expand, it’s essential to understand the platforms we rely on. This review highlights key considerations to improve the rigor, transparency, and applicability of real-world evidence in clinical research.

🔹 حلقة جديدة مهمة جدًا لكل اللي مهتمين بـ GI Fellowship! في حلقة مميزة من ABCDE Podcast – لايف، هيكون معانا د. حازم أبو شعيشع @HazemAbosheaish GI Fellow في TBHC، والرئيس السابق للأطباء المقيمين في Mount Sinai – نيويورك. د. حازم عنده أكتر من 150 بحث منشور، واخد جوائز كبيرة زي AASLD Emerging Liver Scholar Award، وكمان رئيس تحرير مجلة ASIDE Gastroenterology! في الحلقة دي، هيحكيلنا عن رحلته من أول البحث العلمي لحد ما وصل لـ GI Fellowship – خطوة بخطوة. 🎯 هنعرف في الحلقة: إزاي تبدأ وتحضّر كويس لـ GI Fellowship نصايح عملية من تجربته في الريسيرش، والنشر العلمي، والعلاقات المهنية مراحل من رحلته كطبيب وباحث ومرشد فقرة أسئلة مفتوحة تجاوب على كل استفساراتكم 📌 مين لازم يسمع الحلقة؟ النواب والخريجين اللي عايزين يتخصصوا في GI الاطباء المهتمين بالبحث العلمي المينتورز اللي بيساعدوا في التقديم للتخصصات التنافسية 📅 Date: Jul 27. 2025 🕒 Time: 3 PM EST, 10 PM Cairo Time 📍 Live on Zoom – Registration is now open! 🔗 Register here: doctorsforegypt.zohobackstage.com/GIfellowshipDr… #ABCDEPodcast #GastroenterologyFellowship #Hepatology #USResidency #IMGJourney #AcademicMedicine #GIPathway

Another acceptance in the prestigious Journal of Clinical Gastroenterology (JCG) Under the supervision of the rising GI fellow @HazemAbosheaish. #advancedendoscopy #gastroenterology

Honored to return to Digestive Disease Week (DDW) for the third consecutive year as a presenter—this time with even more gratitude and excitement. This year is especially meaningful as I celebrate my GI match with over 20 accepted abstracts, including an oral presentation and a plenary session. Looking forward to connecting with colleagues, sharing ideas, and continuing to contribute to advancing GI and hepatology research. @DDWMeeting @AASLDtweets @AASLDFoundation @GiResearchClub #DDW2025

📢 Excited to share our latest research in ASIDE Gastroenterology! Our systematic review & meta-analysis evaluates dexmedetomidine as an adjunctive sedative in endoscopic submucosal dissection (ESD). Key findings: ✅ Reduces restlessness, improving procedural comfort ✅ No impact on en-bloc or complete resection rates ⚠️ Increased bradycardia, but without major adverse events This study supports dexmedetomidine’s role in enhancing sedation safety & efficacy during ESD. Future research should refine optimal dosing & patient selection. Read more: 🔗 DOI: 10.71079/ASIDE.GI.0109257 @GiResearchClub

Feeling incredibly grateful and reflective as I prepare for the upcoming DDW 2025, where I’ll have 20+ including one plenary session and two oral presentation. This meeting feels different—more meaningful—because it marks a new chapter in my journey. Having recently matched into Gastroenterology, I now find myself not only as a presenter but also stepping into the role of a mentor. It’s been a privilege to guide, supervise, and advise the next generation of researchers and trainees, helping them refine their work and grow. Watching their progress and knowing that we’re all contributing to the advancement of the GI field is deeply rewarding. The transition from being solely a mentee to now paying it forward is a humbling experience. Excited to connect, learn, and continue pushing boundaries in GI research! @DDWMeeting @AmCollegeGastro @AASLDFoundation @AASLDtweets @GiResearchClub

📣 Publication Alert 🔔 Check out our new study at the journal of diabetes and metabolism highlighting the safety of GLP-1 in patients with history of pancreatitis! doi.org/10.1016/j.diab… “Exciting new findings! 🚨 Our TriNetX analysis reveals that GLP-1 receptor agonists (GLP-1RAs) are safe for patients with a history of acute pancreatitis (AP), showing a significantly reduced risk of recurrence compared to DPP-4i and SGLT2i. A step forward in diabetes care! 📉📊 #DiabetesResearch #GLP1RA” @GiResearchClub @MF_Nassar sciencedirect.com/science/articl…